Treatment of Infected Tumor Endoprostheses

王现海,郭卫,杨荣利,汤小东
DOI: https://doi.org/10.3969/j.issn.2095-252x.2007.04.002
2007-01-01
Abstract:Objective To investigate the treatment effect of deep infected tumor endoprostheses. Methods Between July 1997 and January 2006,32 infected patients after massive endoprostheses were treated,including 15 men and 17 women,average age 23.46 years. For the implant locations: 4 proximal femoral implants,12 distal femoral implants,16 proximal tibial implants. Debridement were performed on 9 patients,one-stage reimplantation for 7 patients,gastrocnemius flaps for 4 patients,two-staged reimplantation for 11 patients,and amputation for one. These different operations were analyzed by χ2 analysis. Results All of the 32 patients were followed up on average for 36 months (12-102 months). The success rate of debridement,the gastrocnemius myocutaneous flap,one-stage,two-stage revision surgery for infected endoprostheses was 33.3%(3/9),25.0%(1/4),42.9%(3/7),81.8%(9/11) and100%(1/1). There were statisti-cally significant differences between debridement and two-stage revision. Conclusions Two-stage revision was the better choice for the treatment of deep infected tumor endoprostheses. For primary massive endoprostheses replacement in the proximal tibia,the gastrocnemius myocutaneous flap had a poor effect for the treatment of the deep infected endoprostheses.
What problem does this paper attempt to address?